The Many Faces of Tau
February 11, 2026
Mass spectrometry reveals distinct tau chemistries across Alzheimer’s and related dementias
1 min read
False
Translational Science
Young Blood Slows Alzheimer’s in Mice
February 10, 2026
Proteomics connects exposure to blood from older donors and synaptic dysfunction in the brain
1 min read
Gold Nanostars Take SERS Inside the Biofilm
By James Strachan
January 15, 2026
Steven Bell explains how – and why – he’s tracking antibiotic diffusion in living biofilms
3 min read
Towards a Unified Picture of Chromatin Biology
January 14, 2026
An integrated proteomics-genomics method enables researchers to study chromatin-associated proteins directly and systematically
3 min read
Influenza Screening: Could a Taste-Based Sensor Play a Role?
By Kathryn Wighton
January 13, 2026
Selective methylation of N-acetylneuraminic acid enabled a taste-releasing sensor to distinguish influenza neuraminidase from bacterial enzymes
2 min read
At What Age Do We Have the Strongest Immunity?
January 9, 2026
A multi-omic study defines the immune system’s lifelong trajectory
3 min read
What Happens When You Read DNA and RNA Together?
January 9, 2026
A single-cell DNA–RNA sequencing method connects genetic variation to gene activity in thousands of individual cells
2 min read
Microlaser Droplets Deliver Thousands of Viscosity Readouts in Minutes
By James Strachan
January 8, 2026
A new microscopy platform uses vibrating microlasers – made from picoliter droplets – for real-time, high-throughput lipid assessment
3 min read
Accelerating Biomarker Discovery with AI-Enhanced Omics
By Henry Thomas
December 11, 2025
By fusing multi-omics data with AI, Sapient Founder Mo Jain believes researchers will close the gap between molecular measurement and clinical meaning
10 min read
Pharma and Biopharma
Pharma & Biopharma
Clinical
Trends & Challenges
Proteomics
Translational Science
Could Mass Spec Overcome the CAR T Solid Tumor Barrier?
December 1, 2025
Joey Sheff of the National Research Council Canada explains how mass spectrometry and proteomics could help CAR T therapies overcome the unique challenges of solid tumors
5 min read
